Wikidata

(Q63320217)

English

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

clinical trial

In more languages

Statements

short name
COMMAND-3 (English)
0 references
title
A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared With Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C (English)
0 references
medical condition
hepatitis
0 references
hepatitis A
0 references
hepatitis C
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Canada
0 references
Denmark
0 references
France
0 references
Germany
0 references
Israel
0 references
Italy
0 references
Poland
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
January 2012
0 references
end time
December 2013
0 references
number of participants
605
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63320217&oldid=2149247601"